Remove Biotechnology Remove Management Remove Marketing Remove Succession
article thumbnail

How to Compete Like the World’s Most Innovative Leaders

Skip Prichard

It’s a fascinating study, one that echoes my constant inquiry of the difference between success and failure. You are teaching what separates successful innovators from those who struggle. If Tesla’s ideas ultimately had more impact, then why was Edison so much more successful? Lessons from Tesla versus Edison.

article thumbnail

What Venture Capital Can Learn from Emerging Markets

Harvard Business Review

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In contrast, emerging-market VCs such as Nadathur Holdings (established in 2000 by N.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diverse Boards Are More Innovative

The Horizons Tracker

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 112
article thumbnail

Who's Really Responsible for P&G's Succession Problems?

Harvard Business Review

What kind of signal did this choice send to P&G''s top managers? Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Given the boards'' responsibility for succession planning, one would expect them to give the subject plenty of time and consideration.

article thumbnail

When a Product Fails, Find a New Direction

Harvard Business Review

Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. What do you do next?

article thumbnail

50 Laboratories of Opportunity

Harvard Business Review

When I was teaching at Peking University, for example, one of my fellow professors monitored an experiment in which the Chinese government gave local villagers the rights to manage a forest. Opponents will point out that the discovery of oil and gas can explain a lot of North Dakota's recent success.

article thumbnail

Developing Global Leaders Is America's Competitive Advantage

Harvard Business Review

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.